Figure 9.
T1-weighted images of the abdomen taken using saline solution as the negative control (left) and 30 minutes after the oral administration of the PEG-coated Gd@PBNP suspension (right), showing an unequivocal enhancement of the positive contrast (i.e. T1-weighted) of MRI signals in the abdomen